Pantethine is a high-dose form of vitamin B5 that the body turns into the agent behind its main effect: a genuine but modest lowering of blood fats, most reliably triglycerides and to a smaller degree bad cholesterol. Its standout feature is an exceptional safety record. Effects are largest in those starting with higher blood fats. (Full Review)

Protocol

Standard Dose

600–900 mg/day

Historical range 600–1,200 mg/day; start 300–600 mg and titrate up over 1–2 weeks

Dosing Schedule

Split 2–3×/day with meals

Divided dosing improves tolerability and maintains exposure given rapid metabolism; no specific time of day

Best Candidates

Higher baseline blood fats

Response scales with baseline triglycerides and cholesterol; those with higher starting values most likely to see a worthwhile effect at standard doses

Time to effect

Lipid Changes

4–8 weeks

Triglyceride and cholesterol changes appear with consistent dosing

Confirmed Response

8–16 weeks

Effects measured and confirmed in controlled trials; recheck lipids to verify a real response

Benefits

Medium: Triglyceride reduction; LDL and total cholesterol reduction

Low: HDL cholesterol increase; lipid improvement in specialized populations

Speculative: Fatty liver and fat distribution; neuroprotection and cognitive health; coenzyme A support in energy metabolism

Contraindications

Pregnancy or breastfeeding (high-dose)

Active bleeding risk (high-dose)

Anticoagulant use without medical oversight (high-dose)

Key Interactions

Statins (atorvastatin, simvastatin)

Other cholesterol/triglyceride agents (fibrates, niacin, ezetimibe, red yeast rice)

Anticoagulant/antiplatelet medications (warfarin, clopidogrel, aspirin)

Fish oil/omega-3s

Supplements with additive lipid or antiplatelet effects (omega-3 fish oil, red yeast rice, niacin, garlic, high-dose vitamin E)

Risk & Side Effects

Low: Gastrointestinal disturbance

Speculative: Bleeding tendency via platelet effects; body odor or sulfur-related effects

Monitoring

Marker	Target	Why
Triglycerides	< 80 mg/dL	Most responsive target
LDL cholesterol	< 100 mg/dL (lower if higher risk)	Primary cholesterol target
Apolipoprotein B	< 80 mg/dL	Counts atherogenic particles; tracks true risk
HDL cholesterol	> 50 mg/dL (women), > 40 mg/dL (men)	Tracks possible favorable HDL rise
Total cholesterol	< 180 mg/dL	Overall summary marker
ALT / AST	< 25 U/L (functional)	Confirms no liver stress with use
Fasting glucose	70–90 mg/dL	Screens metabolic context that drives lipids

Cadence: Baseline before starting; recheck at ~8 and 16 weeks, then every 6–12 months during continued use.

Qualitative Assessment

Digestive tolerance (absence of nausea or abdominal discomfort)
General energy levels
Adherence and ease of fitting divided dosing into daily routine

Pantethine for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment